<doc>
  <docmeta id="113s2755is">
    <bill congress="113" type="s" number="2755" version="is"/>
    <revision size="24185" annotations="0" status="complete" id="6" commit-time="2014-08-21T20:36:56Z" committer="mbohmer" doc="113s2755is/6.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-Senate" public-private="public">
	<metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 S2755 IS: Overdose Prevention Act</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. Senate</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2014-07-31</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>2d Session</session>
		<legis-num>S. 2755</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20140731">July 31, 2014</action-date>
			<action-desc>
        <sponsor name-id="S259">Mr. Reed</sponsor> (for himself, <cosponsor name-id="S253">Mr. Durbin</cosponsor>, <cosponsor name-id="S316">Mr. Whitehouse</cosponsor>, <cosponsor name-id="S369">Mr. Markey</cosponsor>, and <cosponsor name-id="S057">Mr. Leahy</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSHR00">Committee on Health, Education, Labor, and Pensions</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To prevent deaths occurring from drug overdoses.</official-title>
	</form>
	<legis-body id="H6A2AD19DCEE647B7B39E7996D54BA40F" style="OLC">
		<section id="HFAB00B70BE604D45B641D51AAD2624C6" section-type="section-one">
			<enum>1.</enum>
			<header>Short title</header>
			<text display-inline="no-display-inline">This Act may be cited as the <quote>
          <short-title>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Overdose Prevention Act" proposed="true">Overdose Prevention Act</cato:entity-ref>
          </short-title>
        </quote>.</text>
		</section>
    <section id="HA026886904A64198B59ED000A0063128">
			<enum>2.</enum>
			<header>Findings</header>
			<text display-inline="no-display-inline">
        <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> finds the following:</text>
			<paragraph id="id8284d759f5bb4ec5a40a0ba87a61c398">
        <enum>(1)</enum>
        <text>According to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7523" entity-type="federal-body">Centers for Disease Control and Prevention</cato:entity-ref>, each day in the United States, more
			 than 100 people die from a drug overdose.  Among people 25 to 64 years
			 old, drug overdose causes more deaths than motor vehicle accidents.</text>
      </paragraph>
      <paragraph id="id65bc3ef8924b463d96a47229a7e77e38">
        <enum>(2)</enum>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7523" entity-type="federal-body">Centers for Disease Control and Prevention</cato:entity-ref> reports that more than 41,000 people in the United
			 States died from a drug overdose in 2011 alone.  Nearly 80 percent of
			 those deaths were due to unintentional drug overdoses, and many could have
			 been prevented.</text>
      </paragraph>
      <paragraph id="ida0cd8da964ec45328a8e364ec9a8229b">
        <enum>(3)</enum>
        <text>Deaths resulting from unintentional drug overdoses increased more than 300 percent between 1980 and
			 1998,	and  nearly tripled between 1999 and 2011.</text>
      </paragraph>
      <paragraph id="id71e55a03c78f4847bab0a345734b0ecd">
        <enum>(4)</enum>
        <text>Ninety-one percent of all unintentional poisoning deaths are due to drugs.  Since 1999, in the
			 United States the population of non-Hispanic Whites and the population of
			 Indians (as defined in <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Indian Self-Determination and Education Assistance Act/s:4">section 4 of the Indian Self-Determination and
			 Education Assistance Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/25/450b">
            <cato:entity-ref entity-type="uscode" value="usc/25/450b">25 U.S.C. 450b</cato:entity-ref>
          </external-xref>)</cato:entity>) have seen the highest rates of
			 unintentional drug poisoning deaths.</text>
      </paragraph>
      <paragraph id="idb6c6a2c63286439a8b008fe076051e55">
        <enum>(5)</enum>
        <text>Opioid medications such as oxycodone and hydrocodone are involved in 55 percent of all
			 unintentional drug poisoning deaths.</text>
      </paragraph>
      <paragraph id="idcc26ec1ac1644a44bee351912e38e84a">
        <enum>(6)</enum>
        <text>Between 1999 and 2010, opioid medication overdose fatalities increased by more than 400 percent
			 among women and 265 percent among men.</text>
      </paragraph>
      <paragraph id="id961f9fb98b184cdab8c6e4aebfbb209a">
        <enum>(7)</enum>
        <text>Military veterans are at elevated risk of experiencing a drug overdose. Veterans who served in
			 Vietnam, Iraq, or Afghanistan and who have combat injuries, posttraumatic
			 stress disorder, and other co-occurring mental health diagnoses are at
			 elevated risk of fatal drug overdose from opioid medications.</text>
      </paragraph>
      <paragraph id="idba890c9325b240dfadb3f0a68a133ba7">
        <enum>(8)</enum>
        <text>Rural and suburban regions are disproportionately affected by opioid medication overdoses. Urban
			 centers also continue to struggle with overdose, which is the leading
			 cause of death among homeless adults.</text>
      </paragraph>
      <paragraph id="id12e9071f40474e2cbfc473ba6af65540">
        <enum>(9)</enum>
        <text>In the year 2009 alone, estimated lost productivity and direct medical costs from opioid medication
			 poisonings exceeded $20,000,000,000.</text>
      </paragraph>
      <paragraph id="id39957005fee248439e98fd62529c4f46">
        <enum>(10)</enum>
        <text>Both fatal and nonfatal overdoses place a heavy burden on public health and public safety
			 resources, yet there is no coordinated cross-Federal agency response to
			 prevent overdose fatalities.</text>
      </paragraph>
      <paragraph id="id2a0c5836930e456f8856d13ea0c3066f">
        <enum>(11)</enum>
        <text>Naloxone is a medication that rapidly reverses overdose from heroin and opioid medications.</text>
      </paragraph>
      <paragraph id="idaade0b84a3404eb894dbe7148c80e3e2">
        <enum>(12)</enum>
        <text>In 2012, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7524" entity-type="federal-body">Food and Drug Administration</cato:entity-ref> held a public workshop in collaboration with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="National Institute on Drug Abuse" entity-parent-id="7500">National
			 Institute on Drug Abuse</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7523" entity-type="federal-body">Centers for Disease Control and
			 Prevention</cato:entity-ref>, and with participation from the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7522" entity-type="federal-body">Substance Abuse and Mental
			 Health Services Administration</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1127" entity-type="federal-body">Office of National Drug Control
			 Policy</cato:entity-ref>, to discuss making naloxone more widely available outside of
			 conventional medical settings to reduce the incidence of opioid overdose
			 fatalities.</text>
      </paragraph>
      <paragraph id="id7e39e068dd5148ad94602f03499003ac">
        <enum>(13)</enum>
        <text>Lawmakers in California, Colorado, Connecticut, Georgia, Illinois, Kentucky, Maine, Maryland,
			 Massachusetts,
			 Minnesota, New Jersey, New Mexico, New York, North
			 Carolina, Ohio, Oklahoma, Oregon, Rhode Island, Tennessee,  Utah, Vermont,
			 Virginia, Washington, Wisconsin, and the District of Columbia have removed
			 legal impediments to increasing naloxone prescription and its use by
			 bystanders who are in a position to respond to an overdose.</text>
      </paragraph>
      <paragraph id="id316594e59a9b4a27818463372d4f46b8">
        <enum>(14)</enum>
        <text>The American Medical Association, the Nation’s largest physician organization, supports further
			 implementation of community-based programs that offer naloxone and other
			 opioid overdose prevention services.</text>
      </paragraph>
      <paragraph id="ida7ced55c52474ac89d758f97b251f92f">
        <enum>(15)</enum>
        <text>Community-based overdose prevention programs have successfully prevented deaths from opioid
			 overdoses by making rescue training and naloxone available to first
			 responders, parents, and other bystanders who may encounter an overdose. A
			 study funded by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7523" entity-type="federal-body">Centers for Disease Control and Prevention</cato:entity-ref> of
			 community-based overdose prevention programs provided by the Massachusetts
			 Department of Public Health found that communities with access to overdose
			 prevention programs experienced lower mortality rates from opioid
			 overdoses than communities that did not have access to overdose prevention
			 programs during the study period.</text>
      </paragraph>
      <paragraph id="idbb5e888d459f47bbb9ce64b2485e202e">
        <enum>(16)</enum>
        <text>Over 50,000 potential bystanders have been trained by overdose prevention programs in the United
			 States. A <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7523" entity-type="federal-body">Centers for Disease Control and Prevention</cato:entity-ref> report credits
			 overdose prevention programs with saving more than 10,000 lives since
			 1996.</text>
      </paragraph>
      <paragraph id="id7cd820711b5246559229c271bbd83fcc">
        <enum>(17)</enum>
        <text>At least 188 local overdose prevention programs are operating in the United States, including in
			 major cities such as Baltimore, Chicago, Los Angeles, New York City,
			 Boston, San Francisco, and Philadelphia, and statewide in New Mexico,
			 Massachusetts, and New York. Between 2006 and 2009, overdose prevention
			 programs facilitated by the Massachusetts Department of Public Health
			 trained more than 4,800 people who reported more than 500 rescues.  Since
			 2004, a program administered by the Baltimore City Health Department has
			 trained more than 3,000 people who reported more than 220 rescues. Project
			 Lazarus, an overdose prevention program in Wilkes County, North Carolina,
			 reduced overdose deaths 69 percent between 2009 and 2011.</text>
      </paragraph>
      <paragraph id="idFDB2F0D1FCA940FB9382BC0524C4939F">
        <enum>(18)</enum>
        <text>In Illinois, the Department of Human Services, Division of Alcoholism and Substance Abuse has
			 enrolled over 20 drug overdose prevention programs with over 100
			 designated sites across Illinois targeting multiple service populations. 
			 These enrollees include police departments, county health departments,
			 medical facilities, licensed substance abuse treatment programs, and
			 community organizations.  Statewide, over 2,000 police officers and more
			 than 600 others have been trained thus far. The DuPage County Illinois
			 Health Department has trained over 1,200 police officers and has reported
			 12 overdose reversals.</text>
      </paragraph>
      <paragraph id="id4b863043eccb4b99bc00e1ec5ebe6d4e">
        <enum>(19)</enum>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1127" entity-type="federal-body">Office of National Drug Control Policy</cato:entity-ref> supports equipping first responders to help reverse
			 overdoses. Police officers on patrol in Quincy, Massachusetts, have
			 conducted 170 overdose rescues with naloxone since 2010. The police
			 department has reported a 95-percent success rate with overdose rescue
			 attempts by police officers.  In Suffolk County, New York, police officers
			 have saved more than 50 lives with naloxone.</text>
      </paragraph>
      <paragraph id="idd0ef2cf289354f15a44e885602d91dc4">
        <enum>(20)</enum>
        <text>Research shows that the cost per year of life gained by making naloxone available to reverse
			 overdoses is within the range of what people in the United States usually
			 pay for health treatments.</text>
      </paragraph>
      <paragraph id="id6980b5db1e7b41688d5d903104d720c3">
        <enum>(21)</enum>
        <text>Overdose prevention programs are needed in correctional facilities, addiction treatment programs,
			 and other places where people are at higher risk of overdosing after a
			 period of abstinence.</text>
      </paragraph>
      <paragraph id="id7af7168004164dda9b39700719a85e9c">
        <enum>(22)</enum>
        <text>People affected by drug overdose gather on August 31 of each year in communities nationwide for
			 Overdose Awareness Day, to mourn and pay tribute to loved ones and raise
			 awareness about overdose risk and prevention.</text>
      </paragraph>
    </section>
    <section id="HA37519D654DD46BA90E44A49B934ABD3">
			<enum>3.</enum>
			<header>Overdose prevention programs</header>
      <text display-inline="no-display-inline">
        <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Public Health Service Act/t:III">Title III of the Public Health Service Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/241">
          <cato:entity-ref entity-type="uscode" value="usc/42/241/etseq">42 U.S.C. 241 et seq.</cato:entity-ref>
        </external-xref>)</cato:entity> is amended by adding at the end
			 the following:</text>
			<quoted-block display-inline="no-display-inline" id="H423DAA62377E4826A695593F2A915C23" style="OLC">
        <part id="id5DF60D4120624D9DBCDD9FBA0A3877DF" style="OLC">
          <enum>W</enum>
          <header>Overdose prevention programs</header>
          <section id="id27C473A9A86849B69D235943D34E0CC6">
            <enum>399OO.</enum>
            <header>Cooperative agreement program to reduce drug overdose deaths</header>
            <subsection id="H31B54C6A46144A04AE257B1B0D9EB34F">
							<enum>(a)</enum>
							<header>Program authorized</header>
							<text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, acting through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7523" entity-type="federal-body">Director of the Centers for Disease Control and Prevention</cato:entity-ref>, shall
			 enter into
			 cooperative agreements
			 with eligible entities to enable the eligible entities to reduce deaths
			 occurring from overdoses of drugs.</text>
						</subsection>
            <subsection id="HB7648E1A7B7E43BDB263D33E681FACF3">
              <enum>(b)</enum>
              <header>Eligible entities</header>
              <text>To be eligible to receive a cooperative agreement under this section, an entity shall be a State,
			 local, or tribal government, a correctional institution, a law enforcement
			 agency, a community agency, a professional organization in the field of
			 poison control and surveillance, or a private nonprofit organization.</text>
            </subsection>
            <subsection id="id8AEFCDF5D77D4D3C8D514AB4C21C782F">
              <enum>(c)</enum>
              <header>Application</header>
							<paragraph id="HFBAEE4F5D85F4BDA9665AC3DB492127D">
								<enum>(1)</enum>
								<header>In general</header>
								<text>An eligible entity desiring a cooperative agreement under this section shall submit to the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> an application at such time, in such manner, and containing such
			 information as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may require.</text>
							</paragraph>
              <paragraph id="H8BCF1FD8B4F24F329D11BD7C85643AD5">
								<enum>(2)</enum>
								<header>Contents</header>
								<text>An application under paragraph (1) shall include—</text>
								<subparagraph id="H902E8F89F5EC4A3DB2FEB8C75D52BD43">
									<enum>(A)</enum>
									<text>a description of the activities to be funded through the cooperative agreement; and</text>
								</subparagraph>
                <subparagraph id="H904DB339E7B34D7C95E6D55F40A6DFC8">
									<enum>(B)</enum>
									<text>evidence that the eligible entity has the capacity to carry out such activities.</text>
								</subparagraph>
              </paragraph>
            </subsection>
            <subsection id="HDF5274B8446D4E4383C13F7AD5052566">
							<enum>(d)</enum>
							<header>Priority</header>
							<text>In entering into cooperative agreements under subsection (a), the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>
			 shall give
			 priority to eligible entities that—</text>
							<paragraph id="H8E6244F489654BC0AA61B4D5940C9111">
								<enum>(1)</enum>
								<text>are a public health agency or community-based organization; and</text>
							</paragraph>
              <paragraph id="H8B3464F964154755A9E7B203F34F3F6E">
								<enum>(2)</enum>
								<text>have expertise in preventing deaths occurring from overdoses of drugs in populations at high risk
			 of such deaths.</text>
							</paragraph>
            </subsection>
            <subsection id="H4BD4EAC73D56410F93B934B2538CE2D3">
							<enum>(e)</enum>
							<header>Eligible activities</header>
							<text>As a condition of receipt of a cooperative agreement under this section, an eligible
			 entity shall agree to use the cooperative agreement to do each of the
			 following:</text>
              <paragraph id="id420D614DB7974435AE8AECF06726F583">
                <enum>(1)</enum>
                <text>Purchase
			 and distribute the drug naloxone or a similarly effective medication.</text>
              </paragraph>
              <paragraph id="id48BDA876EC7C41AE89DC86E3ED5DDAB5">
                <enum>(2)</enum>
                <text>Carry out one or more of the following activities:</text>
                <subparagraph id="H351349FE48DD418285A498A4629AAC43">
									<enum>(A)</enum>
									<text display-inline="yes-display-inline">Educating prescribers and pharmacists about overdose prevention and naloxone prescription, or
			 prescription of a similarly effective medication.</text>
								</subparagraph>
                <subparagraph id="HBF30CDEE79C249CF8B02B29FF3CB3E6F">
									<enum>(B)</enum>
									<text display-inline="yes-display-inline">Training first responders, other individuals in a position to respond to an overdose, and law
			 enforcement and corrections officials on the effective response to
			 individuals who have overdosed on drugs. Training pursuant to this
			 subparagraph may include any activity that is educational, instructional,
			 or consultative in nature, and may include volunteer training, awareness
			 building exercises, outreach to individuals who are at-risk of a drug
			 overdose, and distribution of educational materials.</text>
								</subparagraph>
                <subparagraph id="H691C5AFCEBA64208AC29F4D7B7E98783">
									<enum>(C)</enum>
									<text>Implementing and enhancing programs to provide overdose prevention, recognition, treatment, and
			 response to individuals in need of such services.</text>
								</subparagraph>
                <subparagraph commented="no" id="H8DB9232D7AC840AD9B54AECC8B8C2D1B">
									<enum>(D)</enum>
									<text>Educating the public and providing outreach to the public about overdose prevention and naloxone
			 prescriptions, or prescriptions of other similarly effective medications.</text>
                </subparagraph>
              </paragraph>
            </subsection>
            <subsection commented="no" id="H1CBC985E11AC45A1B828EF670C5BD720">
							<enum>(f)</enum>
							<header>Coordinating center</header>
							<paragraph commented="no" id="HB4D5CE6F06ED4AAA982BC97658835D52">
								<enum>(1)</enum>
								<header>Establishment</header>
								<text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall establish and provide for the operation of a coordinating center responsible
			 for—</text>
								<subparagraph commented="no" id="HE1D8E89B67374CCA8D12B5D5254197B6">
									<enum>(A)</enum>
									<text>collecting, compiling, and disseminating data on the programs and activities under this section,
			 including tracking and evaluating the distribution and use of naloxone and
			 other similarly effective medication;</text>
								</subparagraph>
                <subparagraph commented="no" id="HA4ECA75A4DA441DDAEA208B101A52695">
									<enum>(B)</enum>
									<text display-inline="yes-display-inline">evaluating such data and, based on such evaluation, developing best practices for preventing deaths
			 occurring from drug overdoses;</text>
								</subparagraph>
                <subparagraph commented="no" id="H0E141248C3BA42F0AA390027F5020AD4">
									<enum>(C)</enum>
									<text>making such best practices specific to the type of community involved;</text>
								</subparagraph>
                <subparagraph commented="no" id="id664EDBF4C8AA43CABFCA03747B62EE97">
                  <enum>(D)</enum>
                  <text>coordinating and harmonizing data collection measures;</text>
                </subparagraph>
                <subparagraph id="id343dabb332134ef3975e8f214e8ee5ca">
                  <enum>(E)</enum>
                  <text>evaluating the effects of the program on overdose rates: and</text>
                </subparagraph>
                <subparagraph id="id406e0debc863464cae92680983ed9914">
                  <enum>(F)</enum>
                  <text>education and outreach to the public about overdose prevention and prescription of naloxone and
			 other similarly effective medication.</text>
                </subparagraph>
              </paragraph>
              <paragraph commented="no" id="HA6CE1BD2CDC04F859F5FF83B540DB1BF">
								<enum>(2)</enum>
								<header>Reports to center</header>
								<text>As a condition on receipt of a cooperative agreement under this section, an eligible entity shall
			 agree to prepare and submit, not later than 90 days after the end of the
			 cooperative agreement period, a report to such coordinating center and the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> describing the results of the activities supported through the
			 cooperative agreement.</text>
							</paragraph>
            </subsection>
            <subsection commented="no" id="id01DDD465C3C1468AA3A666893C85A545">
              <enum>(g)</enum>
              <header>Duration</header>
							<text display-inline="yes-display-inline">The period of a cooperative agreement under this section shall be 4 years.</text>
						</subsection>
            <subsection id="HC6A0FBB16910449C950A019B8719690C">
							<enum>(h)</enum>
							<header>Definition</header>
              <text>In this part, the term <term>drug</term> means—</text>
              <paragraph id="id038932C4179A425E8E5850A2ED0E3619">
								<enum>(1)</enum>
								<text>a drug, as defined in <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                    <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:201">section 201 of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref>
			 (<external-xref legal-doc="usc" parsable-cite="usc/21/321">
                    <cato:entity-ref entity-type="uscode" value="usc/21/321">21 U.S.C. 321</cato:entity-ref>
                  </external-xref>)</cato:entity>; and</text>
							</paragraph>
              <paragraph id="id410F249709F441378B732151BCE7AC50">
                <enum>(2)</enum>
                <text>includes controlled substances, as defined in <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                    <cato:entity-ref entity-type="act" value="Controlled Substances Act/s:102">section 102 of the Controlled
			 Substances Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/802">
                    <cato:entity-ref entity-type="uscode" value="usc/21/802">21 U.S.C. 802</cato:entity-ref>
                  </external-xref>)</cato:entity>.</text>
              </paragraph>
            </subsection>
            <subsection id="id533559C04C334B519B208ADF298BE9FE">
              <enum>(i)</enum>
              <header>Authorization of appropriations</header>
							<text>
                <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">There are authorized to be appropriated <cato:funds-and-year amount="20000000" year="2015, 2016, 2017, 2018, 2019">$20,000,000 <cato:property name="purpose">to carry out <cato:entity-ref entity-type="act" value="Public Health Service Act/s:39900" proposed="true">this section</cato:entity-ref>
                    </cato:property> for each of the
			 fiscal years 2015 through 2019</cato:funds-and-year>.</cato:entity>
              </text>
						</subsection>
          </section>
          <section id="H68CF0E8EC5674BBDB5899446560669B9">
						<enum>399OO–1.</enum>
						<header>Surveillance capacity building</header>
						<subsection id="HB393BBF517EF44F0AAF6FE2062A9CF41">
							<enum>(a)</enum>
							<header>Program authorized</header>
							<text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, acting through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7523" entity-type="federal-body">Director of the Centers for Disease Control and Prevention</cato:entity-ref>, shall
			 award cooperative agreements
			 to eligible entities to
			 improve fatal and nonfatal drug overdose surveillance and reporting
			 capabilities, including—</text>
							<paragraph id="HFA7C80EDB4B24C8CBAE855AFB4C7AB05">
								<enum>(1)</enum>
								<text>providing training to improve identification of drug overdose as the cause of death by coroners and
			 medical examiners;</text>
							</paragraph>
              <paragraph id="HA2965AAF8E19470CB6B651DB6D12C739">
								<enum>(2)</enum>
								<text>establishing, in cooperation with the National Poison Data System, coroners, and medical examiners,
			 a comprehensive national program for surveillance of, and reporting to an
			 electronic database on, drug overdose deaths in the United States; and</text>
							</paragraph>
              <paragraph id="HC57DCFCDA2364578BF00792B6155F66E">
								<enum>(3)</enum>
								<text>establishing, in cooperation with the National Poison Data System, a comprehensive national program
			 for surveillance of, and reporting to an electronic database on, fatal and
			 nonfatal drug overdose occurrences, including epidemiological and
			 toxicologic analysis and trends.</text>
							</paragraph>
            </subsection>
            <subsection id="H34867FAE090D4E98A6E50AEBE7024DE5">
							<enum>(b)</enum>
							<header>Eligible entity</header>
              <text>To be eligible to receive a cooperative agreement under this section, an entity shall be—</text>
              <paragraph id="id3D480C62AF494AE0AF435587A91767F5">
                <enum>(1)</enum>
                <text>a State, local, or tribal government; or</text>
              </paragraph>
              <paragraph id="idE6EBCC23D5564449A3174D0838C11A6E">
                <enum>(2)</enum>
                <text>the National Poison Data System
			 working in conjunction with a State, local, or tribal government.</text>
              </paragraph>
            </subsection>
            <subsection id="id5EEE552EFE4C475C97E8E46ABFB93984">
              <enum>(c)</enum>
              <header>Application</header>
							<paragraph id="H59F0FD522BA54094B06FC150DDEC2241">
								<enum>(1)</enum>
								<header>In general</header>
								<text>An eligible entity desiring a
			 cooperative agreement under this section shall submit to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> an
			 application at such time, in such manner, and containing such information
			 as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may require.</text>
							</paragraph>
              <paragraph id="HD0A1E4DF8662487C88F07D2CF1F9687E">
								<enum>(2)</enum>
								<header>Contents</header>
								<text>The application described in paragraph (1) shall include—</text>
								<subparagraph id="HA93B0EBB62E145F18C8CAC4821E39102">
									<enum>(A)</enum>
									<text>a description of the activities to be funded through the cooperative agreement; and</text>
								</subparagraph>
                <subparagraph id="HE8C82777CA154649A4B7FA29A3B2FA24">
									<enum>(B)</enum>
									<text>evidence that the eligible entity has
			 the capacity to carry out such activities.</text>
								</subparagraph>
              </paragraph>
            </subsection>
            <subsection id="H6CD5E42A311243CFBB675E8021D969E8">
							<enum>(d)</enum>
							<header>Report</header>
							<text>As a condition of receipt of a cooperative agreement under this section, an eligible entity shall
			 agree to
			 prepare and submit, not later than 90 days after the end of the
			 cooperative agreement period, a report to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> describing the
			 results of the activities supported through the cooperative
			 agreement.</text>
            </subsection>
            <subsection id="id0ACE23CBC74146568348D28D48C87F5D">
              <enum>(e)</enum>
              <header>National poison data system</header>
              <text>In this section, the term <term>National Poison Data System</term> means the system operated by the American Association of Poison Control Centers, in partnership
			 with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7523" entity-type="federal-body">Centers for Disease Control and Prevention</cato:entity-ref>, for real-time local,
			 State, and national electronic
			 reporting, and the corresponding database network.</text>
            </subsection>
            <subsection id="id8131E2677361443695C5B2F8D19508B1">
              <enum>(f)</enum>
              <header>Authorization of appropriations</header>
							<text>
                <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">There are authorized to be appropriated <cato:property name="purpose">to carry out <cato:entity-ref entity-type="act" value="Public Health Service Act/s:39900-1" proposed="true">this section</cato:entity-ref>
                  </cato:property> <cato:funds-and-year amount="5000000" year="2015, 2016, 2017, 2018, 2019">$5,000,000 for each of the fiscal
			 years 2015 through 2019</cato:funds-and-year>.</cato:entity>
              </text>
						</subsection>
          </section>
          <section id="H25DFCFCD78434E74AC84B219F5981270">
						<enum>399OO–2.</enum>
						<header>Reducing overdose deaths</header>
						<subsection id="H119B3A4FE64347FEB26656C3A9DF8F75">
							<enum>(a)</enum>
							<header>Prevention of drug overdose</header>
							<text>Not later than 180 days after the date of the enactment of this section, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, in
			 consultation with a task force comprised of stakeholders, shall develop a
			 plan to reduce the number of deaths occurring from overdoses of drugs and
			 shall submit the plan to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref>. The plan shall include—</text>
							<paragraph id="HACA46E8E4B35408CB2DEADA402B8D6FD">
								<enum>(1)</enum>
								<text>a plan for implementation of a public health campaign to educate prescribers and the public about
			 overdose prevention and prescription of naloxone and other similarly
			 effective medication;</text>
							</paragraph>
              <paragraph id="H8972FBB171014BD3873091E64EC7707E">
								<enum>(2)</enum>
								<text>recommendations for improving and expanding overdose prevention programming; and</text>
							</paragraph>
              <paragraph id="H5160CBDB05F0452FA5DBFDF05E9376BC">
								<enum>(3)</enum>
								<text>recommendations for such legislative or administrative action as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> determines
			 appropriate.</text>
							</paragraph>
            </subsection>
            <subsection id="H50E677F1CF0D487A8F757A5668DE1354">
							<enum>(b)</enum>
							<header>Task force representation</header>
							<paragraph id="H9418B78E9F864EF4ADD2FED4F906147A">
								<enum>(1)</enum>
								<header>Required members</header>
								<text>The task force under subsection (a) shall include at least one representative of each of
			 the following:</text>
								<subparagraph id="HE447B7AC45D840899ABF471DF820BDF9">
									<enum>(A)</enum>
									<text>Individuals directly impacted by drug overdose.</text>
								</subparagraph>
                <subparagraph id="H9E7C56BC1CF641119AF957780623D718">
									<enum>(B)</enum>
									<text>Direct service providers who engage individuals at risk of a drug overdose.</text>
								</subparagraph>
                <subparagraph id="HD6D06FB2DA1241DC84F8347CD686DF69">
									<enum>(C)</enum>
									<text>Drug overdose prevention advocates.</text>
								</subparagraph>
                <subparagraph id="HBFA3AC93E05241F990114BDF72AC95D4">
									<enum>(D)</enum>
									<text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="National Institute on Drug Abuse" entity-parent-id="7500">National Institute on Drug Abuse</cato:entity-ref>.</text>
								</subparagraph>
                <subparagraph id="H1231CB7D1A1046DCB02FFDE6A30BDA86">
									<enum>(E)</enum>
									<text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Center for Substance Abuse Treatment" entity-parent-id="7500">Center for Substance Abuse Treatment</cato:entity-ref>.</text>
								</subparagraph>
                <subparagraph id="HBF6F80016DDC4F42B847BD8C98D9A30F">
									<enum>(F)</enum>
									<text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7523" entity-type="federal-body">Centers for Disease Control and Prevention</cato:entity-ref>.</text>
								</subparagraph>
                <subparagraph id="HECAD93C8048745079D2F93382002149C">
									<enum>(G)</enum>
									<text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7526" entity-type="federal-body">Health Resources and Services Administration</cato:entity-ref>.</text>
								</subparagraph>
                <subparagraph id="HA17471AE0332405C8C674C426359E90E">
									<enum>(H)</enum>
									<text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7524" entity-type="federal-body">Food and Drug Administration</cato:entity-ref>.</text>
								</subparagraph>
                <subparagraph id="H8430F1CA450D4651B18B8794D83ABEB3">
									<enum>(I)</enum>
									<text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1127" entity-type="federal-body">Office of National Drug Control Policy</cato:entity-ref>.</text>
								</subparagraph>
                <subparagraph id="H4116C4EC5B26408088EF123C7D8D0903">
									<enum>(J)</enum>
									<text display-inline="yes-display-inline">The American Medical Association.</text>
								</subparagraph>
                <subparagraph id="H41CA4959CC0640C79C4CD883C1306EBE">
									<enum>(K)</enum>
									<text display-inline="yes-display-inline">The American Association of Poison Control Centers.</text>
								</subparagraph>
                <subparagraph id="HEBECB8998BF349D6AA463E2DB4493254">
									<enum>(L)</enum>
									<text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1540" entity-type="federal-body">Federal Bureau of Prisons</cato:entity-ref>.</text>
								</subparagraph>
                <subparagraph id="H007FC30BCFA8458BBFFFDDEFB2BFE52E">
									<enum>(M)</enum>
									<text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7530" entity-type="federal-body">Centers for Medicare &amp; Medicaid Services</cato:entity-ref>.</text>
								</subparagraph>
                <subparagraph id="HC4A61825E50A45D68B12260ED9736B79">
									<enum>(N)</enum>
									<text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1500" entity-type="federal-body">Department of Justice</cato:entity-ref>.</text>
								</subparagraph>
                <subparagraph id="idEBA47F592EF643979871719DC2C4A4DB">
                  <enum>(O)</enum>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="9700" entity-type="federal-body">Department of Defense</cato:entity-ref>.</text>
                </subparagraph>
                <subparagraph id="id963A7406B96B43429DEB696023013D78">
                  <enum>(P)</enum>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="3600" entity-type="federal-body">Department of Veterans Affairs</cato:entity-ref>.</text>
                </subparagraph>
                <subparagraph id="id1DF57CA79ED7495CBC3BA5C17D504165">
                  <enum>(Q)</enum>
                  <text>First responders.</text>
                </subparagraph>
                <subparagraph id="idDFAD73B7CFAF4046BCD05D80401ED445">
                  <enum>(R)</enum>
                  <text>Law enforcement.</text>
                </subparagraph>
                <subparagraph id="id1392910FA73F4F7686307EFF1E0FCBC3">
                  <enum>(S)</enum>
                  <text>State agencies responsible for drug overdose prevention.</text>
                </subparagraph>
              </paragraph>
              <paragraph id="HF6D9D86571CF4400AB6EA189A53CA83C">
								<enum>(2)</enum>
								<header>Additional members</header>
								<text>In addition to the representatives required by paragraph (1), the task force under
			 subsection (a) may include other individuals with expertise relating to
			 drug overdoses or representatives of entities with expertise relating to
			 drug overdoses, as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> determines appropriate.</text>
							</paragraph>
            </subsection>
          </section>
        </part>
        <after-quoted-block>.</after-quoted-block>
      </quoted-block>
		</section>
    <section id="H736158C127BF468C87A73B7133890827">
			<enum>4.</enum>
			<header>Overdose prevention research</header>
      <text display-inline="no-display-inline">
        <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Public Health Service Act/t:IV/pt:C/spt:15">Subpart 15 of part C of title IV of the Public Health Service Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/285o">
          <cato:entity-ref entity-type="uscode" value="usc/42/285o/etseq">42 U.S.C. 285o et seq.</cato:entity-ref>
        </external-xref>)</cato:entity> is
			 amended by adding at the end the following:</text>
			<quoted-block display-inline="no-display-inline" id="id8D40FE4FB4994D179B455CC87EC23E20" style="OLC">
        <section id="id7B1B090AB87E44A68A923B6A68F2E86C">
          <enum>464Q.</enum>
          <header>Overdose prevention research</header>
          <subsection id="H549C77AD66C5440BB9F91CBBE5F965C3">
						<enum>(a)</enum>
						<header>Overdose research</header>
						<text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="National Institute on Drug Abuse" entity-parent-id="7500">Director of the Institute</cato:entity-ref> shall prioritize and conduct or support
			 research on drug overdose and
			 overdose prevention. The primary aims of this research shall include—</text>
						<paragraph id="H6FFCD27BD1624EDFBCFCF087AB832180">
							<enum>(1)</enum>
							<text>an examination of circumstances that contribute to drug overdose and identification of drugs
			 associated with fatal overdose;</text>
						</paragraph>
            <paragraph id="H8C2AE7A3EEED462B9FCF4CED26FC3ACC">
							<enum>(2)</enum>
							<text>an evaluation of existing overdose prevention methods;</text>
						</paragraph>
            <paragraph id="HD320F8BBBEFD4BB0BE62029C176D3A02">
							<enum>(3)</enum>
							<text display-inline="yes-display-inline">pilot programs or research trials on new overdose prevention strategies or programs that have not
			 been studied in the United States;</text>
						</paragraph>
            <paragraph id="H44626E81BA2B48B9A5C3BBA44FEA47E0">
							<enum>(4)</enum>
							<text>scientific research concerning the effectiveness of overdose prevention programs, including how to
			 effectively implement and sustain such programs;</text>
						</paragraph>
            <paragraph id="H3A5A53A7709045EDBBFE4868043B1AD0">
							<enum>(5)</enum>
							<text>comparative effectiveness research of model programs; and</text>
						</paragraph>
            <paragraph id="id5EFC0E5CB33744D3AC1329F4ACBBB899">
              <enum>(6)</enum>
              <text>implementation of science research concerning effective overdose prevention programming examining
			 how to implement and sustain overdose prevention programming.</text>
            </paragraph>
          </subsection>
          <subsection id="HFDC0564752E346EDAAA861D3B7A5BABF">
						<enum>(b)</enum>
						<header>Formulations of naloxone</header>
						<text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="National Institute on Drug Abuse" entity-parent-id="7500">Director of the Institute</cato:entity-ref> shall support research on the development of
			 formulations of naloxone, and other similarly effective medications, and
			 dosage delivery devices specifically intended to be used by lay persons or
			 first responders for the prehospital treatment of unintentional drug
			 overdose.</text>
					</subsection>
          <subsection id="H2AB9AFCC71B84B308BB36500E4A07434">
						<enum>(c)</enum>
						<header>Definition</header>
            <text>In this section, the term <term>drug</term> has the meaning given such term in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:399OO" proposed="true">section 399OO</cato:entity-ref>.</text>
          </subsection>
          <subsection id="idCEFD69A85F1B471BB0233E288AB5758C">
            <enum>(d)</enum>
            <header>Authorization of appropriations</header>
						<text>
              <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">There are authorized to be appropriated <cato:property name="purpose">to carry out <cato:entity-ref entity-type="act" value="Public Health Service Act/s:464Q" proposed="true">this section</cato:entity-ref>
                </cato:property> <cato:funds-and-year amount="5000000" year="2015, 2016, 2017, 2018, 2019">$5,000,000 for each of the fiscal
			 years 2015 through 2019</cato:funds-and-year>.</cato:entity>
            </text>
					</subsection>
        </section>
        <after-quoted-block>.</after-quoted-block>
      </quoted-block>
    </section>
  </legis-body>
</bill>
</doc>